Manos Insights
Ideas, strategies, and stories from the frontlines of vertical software. A closer look at how long-term thinking drives performance, leadership, and growth.
Written by
Claio secures seven-figure strategic investment from Valsoft to accelerate AI innovation within Manos Software Group’s healthcare portfolio
Montreal, Canada — October 2025 — Claio, an AI-powered medical scribe platform, today announced it has received a seven-figure strategic investment from Valsoft Corporation. The funding follows a competitive internal R&D program designed to accelerate innovation across Valsoft’s portfolio and will enable Claio to deepen product development, expand integrations with electronic health record (EHR) systems, and enhance AI capabilities that simplify clinicians’ daily workflows.
Launched by the Manos Software Group earlier this year, Claio has achieved rapid adoption among healthcare professionals, onboarding hundreds of users in its first month. Clinicians across multiple specialties—including family medicine, dentistry, plastic surgery, physical therapy, and natural health—now rely on Claio to complete documentation faster and more efficiently. Users report saving an average of 7.5 hours per week on charting while maintaining accuracy and meeting HIPAA compliance and data security standards.
“Clinicians deserve technology that feels effortless,” said Mathis Renier, AI Lead at Claio. “Our goal has always been to build AI that disappears into the background, capturing the context of every patient visit accurately and securely, so healthcare professionals can spend less time documenting and more time caring for their patients. This investment from Valsoft will accelerate that mission and help us expand the capabilities clinicians rely on every day.”
The Manos Software Group, part of Valsoft Corporation, develops and manages vertical market software companies across multiple industries with a focus on artificial intelligence. With this new investment, Claio will deepen its integrations with leading EHR and practice management systems, expand its AI feature set, and broaden its scope to assist clinicians beyond documentation, addressing other time-consuming administrative and communication tasks.
“At Valsoft, we invest in teams that combine deep domain expertise with a clear vision for the future,” said Wissam Alame, Co-Founder of Valsoft Corporation. “Claio represents the next generation of healthcare technology; secure, practical, and designed around real clinician needs. Supporting Claio through this strategic investment reflects our confidence in its mission and our continued commitment to advancing AI innovation across the Manos Software Group portfolio.”
This investment strengthens Claio’s position as a leading innovator within Valsoft’s AI ecosystem and underscores Manos Software Group’s commitment to advancing practical, secure AI solutions across its global portfolio. Together, the teams are focused on developing technologies that redefine how professionals work, connect, and deliver value in the modern SaaS landscape.
About Claio
Claio is an AI-powered medical scribe built to help clinicians reclaim time from documentation. Using advanced speech recognition and large language models, Claio generates accurate, structured clinical notes that integrate seamlessly with existing EHR and practice management systems. The platform is HIPAA-compliant and designed for healthcare professionals across specialties, enabling them to focus on patient care while maintaining efficiency and compliance.
Learn more at claio.ai.
About Manos Software Group
Manos Software Group, a division of Valsoft Corporation, operates a growing portfolio of more than 20 B2B SaaS companies across industries including healthcare, manufacturing, logistics, and communications. Manos’s focus is to drive AI transformation and operational excellence within each business it owns, helping them modernize workflows, increase productivity, and deliver more intuitive software experiences for their clients. With shared expertise, resources, and a long-term investment mindset, Manos enables its portfolio companies to lead in their respective markets.
Learn more at manossoftware.com.
About Valsoft Corporation
Valsoft Corporation acquires and develops mission-critical software companies that deliver essential solutions across multiple vertical markets. Headquartered in Montreal with a global presence, Valsoft builds long-term value by combining operational excellence with a permanent-capital investment model.
For more information, visit valsoftcorp.com.
Media Contact:
Karine LaRocque
Head of Marketing, Manos Software Group
k.larocque@manossoftware.com
